---
title: "MTVA.US (MTVA.US) — Related News"
type: "Symbol"
locale: "en"
url: "https://longbridge.com/en/quote/MTVA.US/news.md"
symbol: "MTVA.US"
name: "MTVA.US"
parent: "https://longbridge.com/en/quote/MTVA.US.md"
datetime: "2026-05-20T00:07:20.491Z"
locales:
  - [en](https://longbridge.com/en/quote/MTVA.US/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/MTVA.US/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/MTVA.US/news.md)
---

# MTVA.US (MTVA.US) — Related News

### [Sector Update: Healthcare Stocks Rise Tuesday Afternoon](https://longbridge.com/en/news/286953270.md)
*2026-05-19T18:02:00.000Z*
> Healthcare stocks rose on Tuesday, with the NYSE Healthcare Index up 1.1% and the State Street Healthcare Select Sector 

### [12 Health Care Stocks Moving In Tuesday's Intraday Session](https://longbridge.com/en/news/286948585.md)
*2026-05-19T17:06:30.000Z*
> On Tuesday, Med Pharmaceuticals (NASDAQ:INM) saw a 127% increase to $1.54, while MetaVia (NASDAQ:MTVA) rose 58.54% to $1

### [12 Health Care Stocks Moving In Tuesday's Pre-Market Session](https://longbridge.com/en/news/286910054.md)
*2026-05-19T12:05:59.000Z*
> In Tuesday's pre-market session, MetaVia (MTVA) shares surged 50.5% to $1.67, while Virax Biolabs (VRAX) rose 38.68% to 

### [MetaVia | 8-K: FY2026 Q1 Revenue: USD 0](https://longbridge.com/en/news/286461115.md)
*2026-05-14T20:15:30.000Z*
### [MetaVia to Present Data Highlighting DA-1726, a GLP-1/Glucagon Dual Agonist, in a Late-Breaking Poster Presentation at the EASL Congress 2026 | MTVA Stock News](https://longbridge.com/en/news/285943285.md)
*2026-05-11T04:31:00.000Z*
> MetaVia Inc. (Nasdaq: MTVA) announced that a late-breaking abstract on DA-1726, a GLP-1/glucagon dual agonist for obesit

### [MetaVia Advances DA-1726 Obesity Trial With First Patient](https://longbridge.com/en/news/282352160.md)
*2026-04-10T13:20:04.000Z*
> MetaVia Inc. has announced the dosing of the first patient in Part 3 of its Phase 1 clinical trial for DA-1726, a dual o